(OXLC) Oxford Lane Capital - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US6915431026
Stock: Collateralized Loan Obligations, Below-Grade Corporate Debt
Total Rating 36
Risk 64
Buy Signal -0.87
Dividends
| Dividend Yield | 28.26% |
| Yield on Cost 5y | 29.24% |
| Yield CAGR 5y | 30.55% |
| Payout Consistency | 92.1% |
| Payout Ratio | 93.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 90.0% |
| Relative Tail Risk | -5.73% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.57 |
| Alpha | -55.86 |
| Character TTM | |
|---|---|
| Beta | 0.782 |
| Beta Downside | 1.003 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.85% |
| CAGR/Max DD | -0.24 |
Description: OXLC Oxford Lane Capital January 15, 2026
Oxford Lane Capital Corp. (NASDAQ: OXLC) is a closed-ended investment fund launched on June 9 2010 and managed by Oxford Lane Management LLC. The fund’s mandate is to invest in fixed-income securities, primarily through securitization vehicles that hold senior secured loans to below-investment-grade or unrated companies.
Based on the most recent Form 10-K (FY 2023) and market data, OXLC reported approximately $1.2 billion in assets under management, a distribution yield near 10 % (annualized), and an average portfolio credit rating of BB-. The fund’s performance is closely tied to the broader leveraged-loan market, which is sensitive to U.S. interest-rate movements and credit-cycle dynamics; a 100-basis-point rise in the 10-year Treasury rate historically compresses loan spreads by roughly 30-40 bps, pressuring net asset value.
For a deeper, data-driven look at OXLC’s valuation and risk profile, you may find ValueRay’s analyst page a useful next step.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 189.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.57 > 0.02 and ΔFCF/TA 17.93 > 1.0 |
| NWC/Revenue: 6.06% < 20% (prev 14.63%; Δ -8.57% < -1%) |
| CFO/TA 0.57 > 3% & CFO 1.52b > Net Income 189.2m |
| Net Debt (469.0m) to EBITDA (271.2m): 1.73 < 3 |
| Current Ratio: 485.3 > 1.5 & < 3 |
| Outstanding Shares: last quarter (87.0m) vs 12m ago 115.2% < -2% |
| Gross Margin: 81.67% > 18% (prev 0.85%; Δ 8083 % > 0.5%) |
| Asset Turnover: 39.08% > 50% (prev 24.99%; Δ 14.09% > 0%) |
| Interest Coverage Ratio: 1.0 > 6 (EBITDA TTM 271.2m / Interest Expense TTM 16.4m) |
Altman Z'' -2.16
| A: 0.02 (Total Current Assets 49.2m - Total Current Liabilities 101.4k) / Total Assets 2.65b |
| B: -0.34 (Retained Earnings -911.7m / Total Assets 2.65b) |
| C: 0.01 (EBIT TTM 16.4m / Avg Total Assets 2.07b) |
| D: -1.16 (Book Value of Equity -910.8m / Total Liabilities 785.4m) |
| Altman-Z'' Score: -2.16 = D |
What is the price of OXLC shares?
As of February 08, 2026, the stock is trading at USD 11.11 with a total of 1,890,016 shares traded.
Over the past week, the price has changed by -8.33%, over one month by -23.64%, over three months by -20.12% and over the past year by -42.96%.
Over the past week, the price has changed by -8.33%, over one month by -23.64%, over three months by -20.12% and over the past year by -42.96%.
Is OXLC a buy, sell or hold?
Oxford Lane Capital has received a consensus analysts rating of 5.00.
Therefore, it is recommended to buy OXLC.
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the OXLC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 16 | 44% |
| Analysts Target Price | 16 | 44% |
| ValueRay Target Price | 15 | 35.3% |
OXLC Fundamental Data Overview February 03, 2026
P/E Trailing = 31.8947
P/S = 2.4118
P/B = 0.743
Revenue TTM = 810.8m USD
EBIT TTM = 16.4m USD
EBITDA TTM = 271.2m USD
Long Term Debt = 481.6m USD (estimated: total debt 488.1m - short term 6.45m)
Short Term Debt = 6.45m USD (from shortTermDebt, last quarter)
Debt = 488.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 469.0m USD (from netDebt column, last quarter)
Enterprise Value = 1.65b USD (1.18b + Debt 488.1m - CCE 19.1m)
Interest Coverage Ratio = 1.0 (Ebit TTM 16.4m / Interest Expense TTM 16.4m)
EV/FCF = 1.09x (Enterprise Value 1.65b / FCF TTM 1.52b)
FCF Yield = 92.14% (FCF TTM 1.52b / Enterprise Value 1.65b)
FCF Margin = 187.0% (FCF TTM 1.52b / Revenue TTM 810.8m)
Net Margin = 23.34% (Net Income TTM 189.2m / Revenue TTM 810.8m)
Gross Margin = 81.67% ((Revenue TTM 810.8m - Cost of Revenue TTM 148.6m) / Revenue TTM)
Gross Margin QoQ = 69.55% (prev none%)
Tobins Q-Ratio = 0.62 (Enterprise Value 1.65b / Total Assets 2.65b)
Interest Expense / Debt = 3.37% (Interest Expense 16.4m / Debt 488.1m)
Taxrate = 21.0% (US default 21%)
NOPAT = 13.0m (EBIT 16.4m * (1 - 21.00%))
Current Ratio = 485.3 (out of range, set to none) (Total Current Assets 49.2m / Total Current Liabilities 101.4k)
Debt / Equity = 0.26 (Debt 488.1m / totalStockholderEquity, last quarter 1.86b)
Debt / EBITDA = 1.73 (Net Debt 469.0m / EBITDA 271.2m)
Debt / FCF = 0.31 (Net Debt 469.0m / FCF TTM 1.52b)
Total Stockholder Equity = 1.65b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.12% (Net Income 189.2m / Total Assets 2.65b)
RoE = 11.47% (Net Income TTM 189.2m / Total Stockholder Equity 1.65b)
RoCE = 0.77% (EBIT 16.4m / Capital Employed (Equity 1.65b + L.T.Debt 481.6m))
RoIC = 0.64% (NOPAT 13.0m / Invested Capital 2.02b)
WACC = 7.00% (E(1.18b)/V(1.67b) * Re(8.80%) + D(488.1m)/V(1.67b) * Rd(3.37%) * (1-Tc(0.21)))
Discount Rate = 8.80% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 46.70%
[DCF Debug] Terminal Value 84.59% ; FCFF base≈1.15b ; Y1≈1.41b ; Y5≈2.41b
Fair Price DCF = 519.6 (EV 50.93b - Net Debt 469.0m = Equity 50.46b / Shares 97.1m; r=7.00% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 6.33 | EPS CAGR: 32.06% | SUE: 4.0 | # QB: 1
Revenue Correlation: 97.54 | Revenue CAGR: 81.60% | SUE: 0.40 | # QB: 0
EPS next Year (2027-03-31): EPS=4.45 | Chg30d=-0.800 | Revisions Net=-1 | Growth EPS=+36.5% | Growth Revenue=+39.1%
P/S = 2.4118
P/B = 0.743
Revenue TTM = 810.8m USD
EBIT TTM = 16.4m USD
EBITDA TTM = 271.2m USD
Long Term Debt = 481.6m USD (estimated: total debt 488.1m - short term 6.45m)
Short Term Debt = 6.45m USD (from shortTermDebt, last quarter)
Debt = 488.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 469.0m USD (from netDebt column, last quarter)
Enterprise Value = 1.65b USD (1.18b + Debt 488.1m - CCE 19.1m)
Interest Coverage Ratio = 1.0 (Ebit TTM 16.4m / Interest Expense TTM 16.4m)
EV/FCF = 1.09x (Enterprise Value 1.65b / FCF TTM 1.52b)
FCF Yield = 92.14% (FCF TTM 1.52b / Enterprise Value 1.65b)
FCF Margin = 187.0% (FCF TTM 1.52b / Revenue TTM 810.8m)
Net Margin = 23.34% (Net Income TTM 189.2m / Revenue TTM 810.8m)
Gross Margin = 81.67% ((Revenue TTM 810.8m - Cost of Revenue TTM 148.6m) / Revenue TTM)
Gross Margin QoQ = 69.55% (prev none%)
Tobins Q-Ratio = 0.62 (Enterprise Value 1.65b / Total Assets 2.65b)
Interest Expense / Debt = 3.37% (Interest Expense 16.4m / Debt 488.1m)
Taxrate = 21.0% (US default 21%)
NOPAT = 13.0m (EBIT 16.4m * (1 - 21.00%))
Current Ratio = 485.3 (out of range, set to none) (Total Current Assets 49.2m / Total Current Liabilities 101.4k)
Debt / Equity = 0.26 (Debt 488.1m / totalStockholderEquity, last quarter 1.86b)
Debt / EBITDA = 1.73 (Net Debt 469.0m / EBITDA 271.2m)
Debt / FCF = 0.31 (Net Debt 469.0m / FCF TTM 1.52b)
Total Stockholder Equity = 1.65b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.12% (Net Income 189.2m / Total Assets 2.65b)
RoE = 11.47% (Net Income TTM 189.2m / Total Stockholder Equity 1.65b)
RoCE = 0.77% (EBIT 16.4m / Capital Employed (Equity 1.65b + L.T.Debt 481.6m))
RoIC = 0.64% (NOPAT 13.0m / Invested Capital 2.02b)
WACC = 7.00% (E(1.18b)/V(1.67b) * Re(8.80%) + D(488.1m)/V(1.67b) * Rd(3.37%) * (1-Tc(0.21)))
Discount Rate = 8.80% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 46.70%
[DCF Debug] Terminal Value 84.59% ; FCFF base≈1.15b ; Y1≈1.41b ; Y5≈2.41b
Fair Price DCF = 519.6 (EV 50.93b - Net Debt 469.0m = Equity 50.46b / Shares 97.1m; r=7.00% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 6.33 | EPS CAGR: 32.06% | SUE: 4.0 | # QB: 1
Revenue Correlation: 97.54 | Revenue CAGR: 81.60% | SUE: 0.40 | # QB: 0
EPS next Year (2027-03-31): EPS=4.45 | Chg30d=-0.800 | Revisions Net=-1 | Growth EPS=+36.5% | Growth Revenue=+39.1%